Barbara Weber

Process Mining Manifesto

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

microRNAs exhibit high frequency genomic alterations in human cancer

Blockchains for Business Process Management - Challenges and Opportunities

Breast and Ovarian Cancer

Change patterns and change support features – Enhancing flexibility in process-aware information systems

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group

Enabling Flexibility in Process-Aware Information Systems